Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “AXSOME THERAPEUTICS, INC.”

127 pharma patents match "AXSOME THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 127
Index total 30,257
Page 2 / 6

Quick answer

This filtered view shows 127 pharmaceutical patents matching "AXSOME THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

127 results for “AXSOME THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 11628173

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  2. US 11617791

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  3. US 11617756

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  4. US 11617755

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  5. US 11607456

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  6. US 11602563

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  7. US 11571428

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

  8. US 11510927

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  9. US 11504429

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  10. US 11471464

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  11. US 11471465

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  12. US 11433079

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

  13. US 11433035

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

  14. US 11433078

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

  15. US 11426414

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  16. US 11369684

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  17. US 11364245

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  18. US 11357854

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  19. US 11351175

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  20. US 11344514

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  21. US 11344513

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  22. US 11331323

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted May 17, 2022 · Expires May 12, 2042

    granted

  23. US 11331285

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 17, 2022 · Expires May 12, 2042

    granted

  24. US 11291639

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.